Nitric Oxide Synthase Inhibitors and the Role of Nitric Oxide in Nociception

[1]  P. Huang,et al.  Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase , 1995, Neuroscience.

[2]  R. Traub,et al.  The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat , 1994, Neuroscience.

[3]  G. Pasternak,et al.  Nitric oxide and opioid tolerance , 1994, Neuropharmacology.

[4]  H. Prast,et al.  Nitric oxide releases acetylcholine in the basal forebrain. , 1992, European journal of pharmacology.

[5]  K. Whitehead,et al.  Inhibition of nitric oxide synthase by 1‐(2‐trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects , 1996, British journal of pharmacology.

[6]  L. Tseng,et al.  Increase of nitric oxide by L-arginine potentiates β-endorphin- but not μ-, δ- or κ-opioid agonist-induced antinociception in the mouse , 1993 .

[7]  S. Ferreira,et al.  Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. , 1990, European journal of pharmacology.

[8]  G. Wilcox,et al.  A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammation , 1996, PAIN®.

[9]  G. Pieper,et al.  Activation of a NO-cyclic GMP system by NO donors potentiates β-endorphin-induced antinociception in the mouse , 1995, Pain.

[10]  O. Hayaishi,et al.  l-NAME, an inhibitor of nitric oxide synthase, blocks the established allodynia induced by intrathecal administration of prostaglandin E2 , 1995, Neuroscience Letters.

[11]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[12]  J. Garthwaite,et al.  NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. , 1989, European journal of pharmacology.

[13]  J. Haley,et al.  Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse , 1992, Neuroscience Letters.

[14]  S. L. Hart,et al.  Characterization of the novel nitric oxide synthase inhibitor 7‐nitro indazole and related indazoles: antinociceptive and cardiovascular effects , 1993, British journal of pharmacology.

[15]  S. L. Hart,et al.  7‐Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti‐nociceptive activity in the mouse without increasing blood pressure , 1993, British journal of pharmacology.

[16]  P. Moore,et al.  Selective inhibitors of neuronal nitric oxide synthase--is no NOS really good NOS for the nervous system? , 1997, Trends in pharmacological sciences.

[17]  L. Tseng,et al.  Inhibition of spinal nitric oxide synthase by N ω -nitro-l-arginine blocks the release of met-enkephalin and antinociception induced by supraspinally administered β-endorphin in the rat , 1997, Neuroscience.

[18]  P. Headley,et al.  The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation , 1994, Neuropharmacology.

[19]  A. Malmberg,et al.  Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats , 1993, Pain.

[20]  J. Garthwaite,et al.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.

[21]  M. Currie,et al.  L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. , 1994, Journal of medicinal chemistry.

[22]  S. Moncada,et al.  Modulation of acute inflammation by endogenous nitric oxide. , 1992, European journal of pharmacology.

[23]  H. Bhargava,et al.  Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine. , 1997, The Journal of pharmacology and experimental therapeutics.

[24]  M. Zhuo,et al.  Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission , 1993, Pain.

[25]  D. Reis,et al.  Agmatine: an endogenous clonidine-displacing substance in the brain. , 1994, Science.

[26]  J. Garthwaite,et al.  The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway , 1996, Neuroscience.

[27]  H. Takagi,et al.  Effect of topical administration of l‐arginine on formalin‐induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation , 1994, British journal of pharmacology.

[28]  R. Przewłocki,et al.  Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. , 1993, Life sciences.

[29]  A. Dickenson,et al.  Amplification of spinal nociceptive transmission depends on the generation of nitric oxide in normal and carrageenan rats , 1996, Brain Research.

[30]  J. Hibbs,et al.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. , 1987, Science.

[31]  E. T. Iwamoto,et al.  Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats. , 1994, The Journal of pharmacology and experimental therapeutics.

[32]  Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse. , 1995, The Journal of pharmacology and experimental therapeutics.

[33]  J. Wood,et al.  Models of the diffusional spread of nitric oxide: Implications for neural nitric oxide signalling and its pharmacological properties , 1994, Neuropharmacology.

[34]  S. Ferreira,et al.  The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. , 1991, European journal of pharmacology.

[35]  K. Whitehead,et al.  The antinociceptive effect of 1‐(2‐trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse , 1995, British journal of pharmacology.

[36]  H. Takagi,et al.  l‐Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin‐Met‐enkephalin pathway and NO‐cyclic GMP pathway , 1993, British journal of pharmacology.

[37]  G. Pasternak,et al.  Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Gebhart,et al.  Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. , 1992, European journal of pharmacology.

[39]  A. Beitz,et al.  Nitric oxide mediates Fos expression in the spinal cord induced by mechanical noxious stimulation. , 1992, Neuroreport.

[40]  S. Ferreira,et al.  The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. , 1992, European journal of pharmacology.

[41]  J. Hoult,et al.  Induction of cyclooxygenase and nitric oxide synthase in endotoxin-activated J774 macrophages is differentially regulated by indomethacin: enhanced cyclooxygenase-2 protein expression but reduction of inducible nitric oxide synthase. , 1996, European journal of pharmacology.

[42]  P. Moore,et al.  A comparison of the effects of L‐NAME, 7‐NI and L‐NIL on carrageenan‐induced hindpaw oedema and NOS activity , 1998, British journal of pharmacology.

[43]  G. Cirino,et al.  Effect of bradykinin antagonists, NG-monomethyl-L-arginine and L-NG-nitro arginine on phospholipase A2 induced oedema in rat paw. , 1991, General pharmacology.

[44]  A. Ianaro,et al.  Modulation by nitric oxide of prostaglandin biosynthesis in the rat , 1995, British journal of pharmacology.

[45]  H. Bhargava,et al.  NG-nitro-L-arginine reverses L-arginine induced changes in morphine antinociception and distribution of morphine in brain regions and spinal cord of the mouse , 1997, Brain Research.

[46]  J. Vane,et al.  Co‐induction of nitric oxide synthase and cyclo‐oxygenase: interactions between nitric oxide and prostanoids , 1995, British journal of pharmacology.

[47]  J. R. Tobin,et al.  Location and Characteristics of Nitric Oxide Synthase in Sheep Spinal Cord and Its Interaction with alpha sub 2 -Adrenergic and Cholinergic Antinociception , 1996, Anesthesiology.

[48]  G. Gebhart,et al.  Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat , 1992, Neuroscience.

[49]  S. L. Hart,et al.  l‐NG‐nitro arginine methyl ester exhibits antinociceptive activity in the mouse , 1991, British journal of pharmacology.

[50]  S. Brain,et al.  Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. , 1990, European journal of pharmacology.

[51]  JD Richardson,et al.  Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent mechanisms , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  E. T. Iwamoto,et al.  Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. , 1994, The Journal of pharmacology and experimental therapeutics.

[53]  R. Przewłocki,et al.  Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. , 1997, The Journal of pharmacology and experimental therapeutics.

[54]  J. Haley,et al.  Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat , 1992, Neuropharmacology.

[55]  J. Eisenach,et al.  Spinal cholinergic alpha-2 adrenergic interactions in analgesia and hemodynamic control: role of muscarinic receptor subtypes and nitric oxide. , 1994, Journal of Pharmacology and Experimental Therapeutics.

[56]  J. Vane,et al.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.